Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A batch-specific COA verifying identity, purity, and mass spectrometry is available on request
Check the salt form: use 286.11 g/mol for molar calculations when the material is the iodide salt (exact mass 285.99670 Da)
Osteogenesis in sintered bone combined with bovine bone morphogenetic protein
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
Choose Injection Sites With Adequate Subcutaneous Tissue Injection sites with minimal subcutaneous fat, such as the inner thigh, the lower abdomen in leaner individuals, or areas close to bony prominences, offer less tissue cushioning between the needle and sensory nerve endings
US$ 27.02
US$ 26.96
US$ 26.67
US$ 29.15
